Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ATYRaTYR PHARMA INCFY2025 · Dec |
|---|---|
| Revenue | $190.00K |
| Revenue, yoy | −19.1% |
| Net income | $74.12M |
| Net income, yoy | −15.8% |
| Net margin | -39,009.5% |
| Free cash flow | $62.06M |
| FCF margin | -32,664.7% |
| EPS, diluted | $0.80 |
Add another company.